Liminatus Pharma, Inc. (LIMN) Insider Trading -- Recent Executive & Director Transactions

2 insiders reported 2 Form 4 transactions for Liminatus Pharma, Inc. (LIMN) over the past 18 months (most recent 2026-07-06). Recent activity: Kim Chris (Chief Executive Officer) Sell 4.4M shares, Valetudo Therapeutics LLC (Insider) Sell 4.4M shares. Source: SEC Form 4.

DateInsiderTitleTypeSharesValue
2026-07-06Kim ChrisChief Executive OfficerSell4.4M$0
2026-07-06Valetudo Therapeutics LLCInsiderSell4.4M$0

Source: SEC Form 4 filings · as of 2026-07-06